Scientists claim New Zealand could miss out on a potential Nobel prize.
CEO hopes for FDA approval for Liberty16 device by year’s end.
GCSB director-general gives insights into hackers.
More than 200 staff at Zag’s NZ and Australian offices will join Accenture.
London-based Gary Miles has taken on the role.
A restricted wholesale investor offer raised $75,000.
Bartlett is suffering ill health.
UPDATED: Shareholders liked the news.
Analyst says Serko is benefitting from halo effect following Booking.com deal.
CEO says the company aims to have chosen a path by year’s end.